Warfarin
9
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
22%
2 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (9)
A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam
Inr Tracking Coumadin Use With Phone App
Warfarin Dosage Adjustment Model Analysis Study
Study on the Significance of Auricular Clip in Prevention and Treatment of Valvular Heart Disease Atrial Thrombosis
Impact of Telephone Follow-up in Patient's Health-related Quality of Life That Use Warfarin
The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
Does Anticoagulant Control Change Following Referral Back to the Primary Care Physician?
Daily Vitamin K in Patients on Warfarin With Unstable INRs
Patient Self Testing of Warfarin Therapy